Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA


NEW YORK, Nov. 25, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation ("Liquidia" or the "Company") (NASDAQ: LQDA).  Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Liquidia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On November 25, 2020, Liquidia announced that the U.S. Food and Drug Administration ("FDA") had issued a complete response letter ("CRL") for the Company's New Drug Application ("NDA") for LIQ861 (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension.  Specifically, the Company advised, among other things, that "[i]n the CRL, the FDA stated that it is unable to approve the NDA at this time," citing "the need for additional information and clarification on chemistry, manufacturing and controls (CMC) data pertaining to the drug product and device biocompatibility."  On this news, Liquidia's stock price fell $0.16 per share, or 5.16%, to close at $2.94 per share on November 25, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com 
888-476-6529 ext. 7980

 

SOURCE Pomerantz LLP


These press releases may also interest you

at 22:35
GCL System Integration Technology Co. Ltd ("GCLSI " or "the Company")(Shenzhen:002506), a leading photovoltaics(PV) company in China, announced on January 21 that it successfully raised 2.5 billion yuan ($US386 million) through a private placement...

at 22:00
Fortistar Sustainable Solutions Corp. (the "Company"), a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more...

at 21:35
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First, A National Banking Association, (www.thefirstbank.com) reported today net income available to common shareholders for the quarter ended December 31, 2020....

at 21:25
Dorel Industries Inc. ("Dorel") announces that it intends to appeal a decision of the Luxembourg Administrative Tribunal received on January 22, 2021 with respect to taxation on the transfer of certain assets in connection with an internal corporate...

at 21:13
Parkit Enterprise Inc. ("Parkit" or the "Company") , is pleased to announce that it has entered into an agreement with Stifel GMP and Scotiabank as joint bookrunners on their own behalf and on behalf of a syndicate of underwriters (collectively, the...

at 21:00
Alibaba Cloud, the digital technologies and intelligence backbone of Alibaba Group, has continued to support a growing number of enterprises across Asia with their accelerated digital transformation progress to meet pandemic-imposed challenges in...



News published on 25 november 2020 at 23:10 and distributed by: